Examples of the use of stable isotope resolved metabolomics can be found in the publications listed below:
Fan, T.WM., Lane, A.N., Higashi, R.M., Farag, M.A., Gao, H., Bousamra, M. & Miller, D.M. (2009) Altered Regulation of Metabolic Pathways in Human Lung Cancer Discerned by 13C Stable Isotope-Resolved Metabolomics (SIRM). Molecular Cancer. 8:41
Fan, T. W-M., Lane, A.N., Higashi, R.M., Yan, J. (2011) Stable Isotope Resolved Metabolomics of Lung Cancer in a SCID Mouse Model. Metabolomics 7, 257-269
Le, A., Lane, A.N., Hamaker, M., Bose, S., Barbi, J., Tsukamoto, T., Rojas, C.J., Slusher, B.S., Zhang, H., Zimmerman. L.J., Liebler, D.C., Slebos, R.J.C., Lorkiewicz, P.K., Higashi, R.M., Fan, T.W-M., and Dang, C.V. (2012) Myc induction of hypoxic glutamine metabolism and a glucose-independent TCA cycle in human B lymphocytes. Cell Metabolism. 15, 110-121
Yang, Y., Lane, A.N., Fan, T.W-M., Rickets, C., Wu, M., Boros, L., Linehan, W.M. (2013) Understanding How Fumarate Hydratase (FH) Null Cells Use its Central Carbon for Energy and Malignant Development PlosOne 8, e72179
Sellers, K., Fox, M.P., Bousamra, M., Slone, S., Higashi, R.M.,Miller, D.M., Wang, Y., Yan, J., Yuneva, M., Deshpande, R., Lane, A.N., Fan, T. W-M. (2015) Pyruvate carboxylase is upregulated in NSCLC. J Clin Invest. 125(2): 687-698
The review by Fan, T.W-M., Lorkiewicz, P., Sellers, K., Moseley, H.N.B., Higashi, R.M., Lane, A.N. (2012). Stable isotope-resolved metabolomics and applications to drug development. Pharmacology & Therapeutics. 133:366-391 is also a good background source of examples.
Our Handbook of Metabolomics, The Handbook of Metabolomics Methods in Pharmacology and Toxicology, vol. 17, Humana Press 2012. DOI 10.1007/978-1-61779-618-0_4